3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma, Ewing
1
Sarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Lymphoma, Follicular
1
Genetic Predisposition to Disease
1
Interventions
Filgrastim
13
Peripheral Blood Stem Cell Transplantation
10
Melphalan
9
Ifosfamide
9
Etoposide
9
Cyclophosphamide
8
Thiotepa
6
Carboplatin
6
Busulfan
6
Radiotherapy
5
Doxorubicin
5
Vincristine
3
Topotecan
3
Temozolomide
3
Docetaxel
3
trioctyl phosphine oxide
2
temsirolimus
2
etoposide phosphate
2
Transplantation
2
Surgical Procedures, Operative
2
Stem Cell Transplantation
2
Radiotherapy, Intensity-Modulated
2
Microarray Analysis
2
Mesna
2
Granulocyte Colony-Stimulating Factor
2
Gemcitabine
2
Dexrazoxane
2
Cisplatin
2
Bone Marrow Transplantation
2
Amifostine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neuroectodermal Tumors, Primitive, Peripheral
×
Genome-Wide Association Study
×
Clear all
NCT01210209
2021-05-19
GENEWING
Institut Curie
Completed
350 enrolled